// App-Quantinova.ai

TCT-439 : Increased incidence of revascularization in diabetic patients treated with the ABSORB everolimus-eluting bioresorbable scaffold: 24-months clinical results

Researchers

Presenter

  • Robin Kraak

Principal Investigators

  • Joelle Elias

  • Deborah Kalkman

  • Joanna Wykrzykowska

  • Karel Koch

  • Jose PS

  • Henriques

  • Jan Piek

  • Jan Baan

  • Marije Vis

  • Jan Tijssen

  • Robert de Winter

Medical Centers

  • VUmc, Amsterdam, Netherlands

  • Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands

  • VU Amsterdam, Amsterdam, Netherlands

  • Academic Medical Center, Amsterdam, Netherlands

  • AMC Heartcentre, Academic Medical Centre - Un, Amsterdam, Netherlands

  • AMC-UVA, Naarden, Netherlands

  • Academic Medical Center, Amsterdam, Netherlands

  • University of Amsterdam, Amsterdam, Netherlands

  • Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Myocardial infarction

  • Venous thrombosis

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved